Literature DB >> 28035631

Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.

Iftach Sagy1,2, Alan Jotkowitz3, Leonid Barski3.   

Abstract

Jehovah's witnesses oppose receiving blood transfusions based on religious grounds. This refusal raises complex medical, legal and ethical issues for the treating medical staff. In the past physicians attempted to force patients and children to accept transfusions when deemed medically necessary through the use of court orders. However, in recent years the threshold for blood transfusion has been gradually raised by medical experts as expressed in consensus guidelines, which means that Jehovah's witnesses' aversion to transfusion would have been partially justified medically. This article will further discuss these current trends.

Entities:  

Keywords:  Blood aversion; Blood transfusion; Hemoglobin threshold; Jehovah’s witness

Mesh:

Year:  2017        PMID: 28035631     DOI: 10.1007/s10943-016-0353-1

Source DB:  PubMed          Journal:  J Relig Health        ISSN: 0022-4197


  41 in total

1.  Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's witnesses.

Authors:  O Muramoto
Journal:  BMJ       Date:  2001-01-06

2.  Liberal or restrictive transfusion in high-risk patients after hip surgery.

Authors:  Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner
Journal:  N Engl J Med       Date:  2011-12-14       Impact factor: 91.245

3.  Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.

Authors:  Colm Keane; Peter Mollee; Paula Marlton; Devinder Gill
Journal:  Ann Hematol       Date:  2010-07-06       Impact factor: 3.673

4.  Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization.

Authors:  Akiko Tanaka; Takeyoshi Ota; Nir Uriel; Zewditu Asfaw; David Onsager; Vassyl A Lonchyna; Valluvan Jeevanandam
Journal:  J Thorac Cardiovasc Surg       Date:  2015-06-30       Impact factor: 5.209

5.  Conservative management of placenta previa percreta in a Jehovah's Witness.

Authors:  Alan Weinstein; Prasanta Chandra; Henry Schiavello; Adiel Fleischer
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

6.  Treatment of acute myeloid leukemia in a Jehovah's Witness.

Authors:  Shail Dalal; Manoranjan Boddapati; Mary N Lowery; Diana M Veillon; Jonathan Glass; Reinhold Munker
Journal:  Ann Hematol       Date:  2006-03-04       Impact factor: 3.673

Review 7.  The Mental Capacity Act 2005--implications for anaesthesia and critical care.

Authors:  S M White; T J Baldwin
Journal:  Anaesthesia       Date:  2006-04       Impact factor: 6.955

Review 8.  Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger.

Authors:  J K Wang; H G Klein
Journal:  Vox Sang       Date:  2009-08-04       Impact factor: 2.144

Review 9.  Bioethics of the refusal of blood by Jehovah's Witnesses: Part 1. Should bioethical deliberation consider dissidents' views?

Authors:  O Muramoto
Journal:  J Med Ethics       Date:  1998-08       Impact factor: 2.903

Review 10.  Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review.

Authors:  Shelley R Salpeter; Jacob S Buckley; Saurav Chatterjee
Journal:  Am J Med       Date:  2013-10-07       Impact factor: 4.965

View more
  1 in total

1.  Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity.

Authors:  Titilope Olanipekun; Temidayo Abe; Valery Effoe; Abimbola Chris-Olaiya; Isaac Biney; Pramod Guru; Charles Ritchie; Devang Sanghavi
Journal:  J Thromb Thrombolysis       Date:  2022-10-11       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.